Opiant Pharmaceuticals, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Opiant Pharmaceuticals, Inc.
Quantité totale PI 21
Rang # Quantité totale PI 72 186
Note d'activité PI 2/5.0    12
Rang # Activité PI 72 813
Symbole boursier OPNT (nasdaq)
ISIN US6837501039
Capitalisation 31.20M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

0 2
0 6
13 0
0
 
Dernier brevet 2023 - Compositions and methods for the...
Premier brevet 2015 - Nasal drug products and methods ...
Dernière marque 2022 - OPIANT
Première marque 2018 - REVEX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 P/S Development of pharmaceutical preparations and medicines; pharmaceutical drug development service...
Invention Compositions and methods for the treatment of opioid overdose. Drug products adapted for nasal de...
P/S Pharmaceutical drug development services; pharmaceutical research services; development of pharma...
P/S Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharm...
P/S Pharmaceutical preparations for the treatment of neurological and psychological addictions, namel...
P/S Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; Pharm...
2021 Invention Nasal drug products and methods of their use. Drug products adapted for nasal delivery, comprisi...
2020 Invention Compositions and methods for treating acute cannabinoid overdose with a cannabinoid receptor anta...
Invention Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid recepto...
2019 Invention Compositions, devices, and methods for the treatment of overdose and reward-based disorders. Drug...
Invention Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdos...
Invention Formulations and methods for the prevention of opioid overdose. Formulations and methods for the ...
2017 Invention Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions. Drug...
Invention Treatment with intranasal naloxone. Methods of achieving high levels of naltrexone occupancy of t...
Invention Co-packaged drug products. Provided herein are drug products comprising a combination of an opio...
Invention Compositions, devices, and methods for the treatment of alcohol use disorder. Drug products adapt...
2015 Invention Co-packaged drug products. Provided herein are drug products comprising a combination of an opioi...
Invention Nasal drug products and methods of their use. Drug products adapted for nasal delivery, comprisin...